| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/17/2005 | US20050059600 Chimeric natriuretic peptides |
| 03/17/2005 | US20050059599 Elastin peptide analogs and uses thereof |
| 03/17/2005 | US20050059593 From Vibrio cholerae phage; cadherins; immunogens; drug screening; for treatment of autoimmune and gastrointestinal diseases, food allergies, and Celiac disease; vaccines; antibodies |
| 03/17/2005 | US20050059591 Prevention and treatment of amyloidogenic disease |
| 03/17/2005 | US20050059590 Modified IL-4 mutein receptor antagonists |
| 03/17/2005 | US20050059588 Human anion exchange protein; antigen presenting cells; for treatment of diabetes, thalassemia, sickle cell anemia, and falciparum malaria |
| 03/17/2005 | US20050059587 Use of a protein for the production of a medicament for stimulating the innate non-specific immune system |
| 03/17/2005 | US20050059586 For increasing expression of human presenilin; for treatment of neurodegenerative diseases, Alzheimer's disease; drug screening |
| 03/17/2005 | US20050059585 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 03/17/2005 | US20050059584 Stroma cell-derived factor (SDF-1) and/or SDF-1/macrophage inflammatory protein (MIP1) alpha hybrid analogs; for increasing hemocrit, mobilizing stem cells, vaccine production, or gene therapy; for mobilizing intracellular calcium and leukocytes |
| 03/17/2005 | US20050059577 Glycosylphosphatidylinositol containing polypeptides |
| 03/17/2005 | US20050059575 Assays |
| 03/17/2005 | US20050059149 Methods of ex-vivo expansion of hematopoeitic cells using multivariant IL-3 hematopoiesis chimera proteins |
| 03/17/2005 | US20050059145 Compositions for the in vitro derivation and culture of embryonic stem (es) cell lines with germline transmission capability and for the culture of adult stem cells |
| 03/17/2005 | US20050059144 MHC class II antigen-presenting systems and methods for activating CD4+ T cells |
| 03/17/2005 | US20050059135 Methods and compositions for identifying receptor effectors |
| 03/17/2005 | US20050059132 Variant blood coagulation factor for use as tool in treatment of thrombosis |
| 03/17/2005 | US20050059127 Method for recovering proteins from the interstitial fluid of plant tissues |
| 03/17/2005 | US20050059122 Targeted carrier fusions for delivery of chemotherapeutic agents |
| 03/17/2005 | US20050059121 Colony stimualting factor for use in animal vaccination and as nonspecific immunity stimulant; veterinary medicine |
| 03/17/2005 | US20050059120 Using allergen induced cytokines as tool in diagnosing inflammatory bowel disease |
| 03/17/2005 | US20050059119 Natural insulin B chain lacking the B30 amino acid residue and a natural insulin A chain, a peptide sequence of one Pro not longer than 10 amino acid residues in length; connecting peptide with a cleavage site at its C-terminal |
| 03/17/2005 | US20050059118 Hyaluronan receptor for endocytosis |
| 03/17/2005 | US20050059117 Nucleotide sequences coding endothelial growth factor for use as tools in treatment and prevention of cell prolifreative disorders; antitumor agents |
| 03/17/2005 | US20050059116 Compositions and methods for inhibiting G2 cell cycle arrest and sensitizing cells to DNA damaging agents |
| 03/17/2005 | US20050059115 Using biglycan protein to diagnose, prevent and treatment of cell proliferative disorders |
| 03/17/2005 | US20050059114 Expression vector comprising nucleotide sequences coding platelet activating factor receptor (PAF) for use in identifying modulator for prevention and treatment of nervous ssytem, bone, hypotensive, heart and urogenital disorders |
| 03/17/2005 | US20050059111 Pichia methanolica secretory signal |
| 03/17/2005 | US20050059110 Human nervous system-associated proteins |
| 03/17/2005 | US20050059109 Methods and compositions for polypeptide engineering |
| 03/17/2005 | US20050059108 Expression vector comprising nucleotide sequences coding neurotransmitter for use in prevention and treatment of obesity, anorexia, energy imbalance, diabetes, dyslipidemia, hypertension and/or insulin resistance |
| 03/17/2005 | US20050059107 Method of selecting hla-dp4 ligands and the applications thereof |
| 03/17/2005 | US20050059106 Antisense oligonucleotide for use in controlling genes associated with carbon regulationin bacteria; prevention of infection; bactericides |
| 03/17/2005 | US20050059103 Detecting immune response signature and mycobacterial infection; immunodiagnostics |
| 03/17/2005 | US20050059102 Monoclonal antibody for use in diagnosis, prevention and treatment of cell proliferative disorders; immunotherapy; immunodiagnostics |
| 03/17/2005 | US20050059099 PSCA: prostate stem cell antigen and uses thereof |
| 03/17/2005 | US20050059093 Method for detecting modulators of Notch signalling |
| 03/17/2005 | US20050059089 Complexes of GPCR142 and relaxin3 or INSL5, and their production and use |
| 03/17/2005 | US20050059079 Expression vector comprising nucleotide sequences associated with neuropsychological disruption for use in diagnosis, prevention and treatment of schizophrenia, mood and bipolar disorders |
| 03/17/2005 | US20050059073 Expression vector comprising nucleotide sequences coding cell growth factors for use in treatment and prevention of nervous system disorders |
| 03/17/2005 | US20050059071 Diagnosing age related and cardiovascular disorders using variation in lamin a gene expression profiles |
| 03/17/2005 | US20050059061 Beta, beta-carotene 15,15'-enzymes, nucleic acid sequences coding therefor and their use |
| 03/17/2005 | US20050059058 Oligonucleotide sequences coding integral membrane proteins (ZIPA) for use as tool in identifying bactericidal agents; microbiocides; drug screening |
| 03/17/2005 | US20050059056 Antigenic gp100 (154-162) compounds for therapy and diagnosis and methods for using same |
| 03/17/2005 | US20050059053 Generating plants comprising polypeptides with enhanced properties; directed evolution of proteins; bioreactor and heterologous gene expression |
| 03/17/2005 | US20050059051 Expression vector comprising nucleotide sequences coding transmembrane protein for use as tool in stimulating lymphocyte response and treatment and prevention of inflammatory and autoimmune diseases |
| 03/17/2005 | US20050059050 Novel human ion-exchanger proteins and polynucleotides encoding the same |
| 03/17/2005 | US20050059040 Guidance receptor protein for use as tool in identifying modlator for use in treatment and preventio of nervous system disorders |
| 03/17/2005 | US20050059036 interactions with the fluorescent ligand are then detected by means of the changes in the donor's and acceptor's excitation and/or emission energy spectra; ligands are defined as being pharmacologically significant if interaction with target protein is inhibited by the addition of non-fluorescent ligand |
| 03/17/2005 | US20050059035 Nucleotide sequences coding cystic fibrosis transmembrane conductance regulator (CFTR) protein for use in diagnosis prevention and treatment of respiratory system, pulmonary and pancreatic disorders |
| 03/17/2005 | US20050059026 Using concentration of degraded or soluble matrix protein as diagnostic indicator of degree of apoptosis/necrosis in cell tissue |
| 03/17/2005 | US20050059018 Virulence-associated nucleic acids and proteins and uses thereof |
| 03/17/2005 | US20050059015 A nucleotide sequence and a complement used to screen, diagnose and monitor individuals for obesity and/or diabetes by detecting the presence, absence, or quantity of a translation product of a transcript having a sequence selected from the group of amino acid sequences; antidiabetic agents |
| 03/17/2005 | US20050059013 Use of biomarkers for detecting ovarian cancer |
| 03/17/2005 | US20050059012 Using human epithelial membrane protein 1 sequences as diagnostic tool in detection cell proliferative disorders and antitumor resistant genic variation |
| 03/17/2005 | US20050059011 Amplification and overexpression of oncogenes |
| 03/17/2005 | US20050059010 Macular degeneration diagnostics and therapeutics |
| 03/17/2005 | US20050059007 Using microarray comprising four immobilzed nucleotide sequences to identify variations associated with glucose transport protein expression; using polymorphic expression to diagnose diabetes |
| 03/17/2005 | US20050059002 Novel serine protease |
| 03/17/2005 | US20050059001 Nucleic acids isolated in neuroblastoma |
| 03/17/2005 | US20050058999 Gene involved in apoptosis regulation |
| 03/17/2005 | US20050058997 Method for defining, identifying and isolating fatty acid and retinal binding protein complexes having immuno-suppressive activity |
| 03/17/2005 | US20050058994 Epitopes; immunoglobulins; hybridomas; diagnostic kits |
| 03/17/2005 | US20050058993 Method and device for detecting feline immunodeficiency virus |
| 03/17/2005 | US20050058992 Method and device for detecting feline immunodeficiency virus |
| 03/17/2005 | US20050058989 Grapevine leafroll virus proteins and their uses |
| 03/17/2005 | US20050058988 for identification and vaccination of human papillomavirus; |
| 03/17/2005 | US20050058987 Reverse genetics system for screening viricides; immunotherapy |
| 03/17/2005 | US20050058984 Novel methods for displaying (poly)peptides/proteins on bacteriophage particles via disulfide bonds |
| 03/17/2005 | US20050058756 High temperature extraction using alkaline solution of sodium bicarbonate to remove mucilage; concentration; isoelectric precipitation; crushing to recover oil and leave meal; egg white substitutes; feeds, foods, nutritional supplements, cosmetics |
| 03/17/2005 | US20050058703 Single molecular species genetically engineered gelatin and plasticizer |
| 03/17/2005 | US20050058664 Infectious bursal disease virus (IBDV) mutant expressing virus neutralising epitopes specific for classic-and variant IBDV strains |
| 03/17/2005 | US20050058662 Novel type III secretion pathway in Aeromonas salmonicida, and uses therefor |
| 03/17/2005 | US20050058661 Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus Borrelia |
| 03/17/2005 | US20050058660 Novel surface antigen |
| 03/17/2005 | US20050058659 Forming fusion peptides with 14 to 75 amino acids in prokaryotic host cell and encoding fusion peptide for expression vectors |
| 03/17/2005 | US20050058658 Treatment for HIV infections by stimulation of immune response in subjects by immunotherapy using proteins with immune therapy response to treat viruses |
| 03/17/2005 | US20050058657 Vaccines for treatment of Aids |
| 03/17/2005 | US20050058656 Peptide sequences for immunization in veterinary medicine |
| 03/17/2005 | US20050058655 Vaccine and kit for viral disease in swine and diagnosis of diseases |
| 03/17/2005 | US20050058654 For therapy of cancers, autoimmune diseases, immunodeficiency diseases, reperfusion injuries, and neurodegenerative diseases |
| 03/17/2005 | US20050058653 Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2 |
| 03/17/2005 | US20050058651 Compositions and methods to prevent metastasis from primary malignancies |
| 03/17/2005 | US20050058646 Compositions and methods for treating cellular response to injury and other proliferating cell disorders regulated by hyaladherin and hyalurons |
| 03/17/2005 | US20050058643 Binding to major histocompatibility complex; immunosuppression; therapy, prevention multiple sclerosis |
| 03/17/2005 | US20050058642 Antagonists and agonists of LDCAM and methods of use |
| 03/17/2005 | US20050058637 Therapy, prevention of viral infections; obtaining viron sample; incubation, monitoring, calibration: using antithrombin agent |
| 03/17/2005 | US20050058626 Vaccine against pathogens |
| 03/17/2005 | US20050058625 IL-1 delta DNA and polypeptides |
| 03/17/2005 | US20050058624 Fusion proteins; adjust half-life; septic shock, diabetes, antiinflammatory agents |
| 03/17/2005 | US20050058621 Derivatives of growth hormone and related proteins, and methods of use thereof |
| 03/17/2005 | US20050058620 Modified bio-related substance, process for producing the same, and intermediate |
| 03/17/2005 | US20050058599 Human kininogen D3 domain polypeptide as an anti-angiogenic and anti-tumor agent |
| 03/17/2005 | DE10339820A1 Use of G-protein coupled receptor, GPR49, peptides, protein and nucleic acid, for diagnosis and prognosis of tumors, also in screening for therapeutic and diagnostic agents |
| 03/17/2005 | CA2579635A1 Peptides that inhibit complement activation |
| 03/17/2005 | CA2540198A1 Tick engorgement factor proteins |
| 03/17/2005 | CA2538012A1 Cyclic nucleotide-specific phosphodiesterases from leishmania and uses thereof |
| 03/17/2005 | CA2537995A1 Compositions and methods for inhibiting white spot syndrome virus (wssv) infection |
| 03/17/2005 | CA2537968A1 Methods and kits for detection of prion diseases |
| 03/17/2005 | CA2537844A1 Treatment of neurodegenerative diseases |